A long non-coding RNA in early and late-stage breast cancer as a prognostic marker, diagnostic marker, and therapeutic target.

by | Nov 8, 2023 | Eteleeb, Abdallah, Maher, Christopher, Silva-Fisher, Jessica

— Technology Description

Researchers in Dr. Jessica Silva-Fisher’s laboratory have developed antisense oligonucleotide targeting a long non-coding RNA (lncRNA), LINC00355, as a treatment for late-stage relapse (LSR) breast cancer. LINC00355 is highly expressed in LSR breast cancer patients and…